| 000 | 01532 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516091013.0 | ||
| 264 | 0 | _c20120724 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/cp201521 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhandave, Suhas S | |
| 245 | 0 | 0 |
_aBioequivalence study of two losartan tablet formulations with special emphasis on cardiac safety. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cMay 2012 |
||
| 300 |
_a349-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLosartan _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aSawant, Satish V | |
| 700 | 1 | _aSahane, Rakhi V | |
| 700 | 1 | _aMurthi, Vivekanand | |
| 700 | 1 | _aDhanure, Shivanand S | |
| 700 | 1 | _aSurve, Pradeep G | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 50 _gno. 5 _gp. 349-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cp201521 _zAvailable from publisher's website |
| 999 |
_c21739411 _d21739411 |
||